Graves' disease in patients with 22q11.2 deletion.

Kawame, H; Adachi, M; Tachibana, K; Kurosawa, K; Ito, F; Gleason, M M; Weinzimer, S; Levitt-Katz, L et al. · J Pediatr · 2001

case_report · Level V

Where this comes from

Abstract

We report 4 female patients and 1 male patient with a 22q11.2 deletion and Graves' disease diagnosed at age 27 months, 7, 10, 17, and 16 years, respectively. The clinical presentations were typical for hyperthyroidism, but 1 female infant had seizures in addition to symptoms of hyperthyroidism. All patients had elevated serum levels of thyroid hormones in association with suppressed thyroid-stimulating hormone levels. From these observations, we suggest that Graves' disease may be a part of the clinical spectrum associated with the 22q11.2 deletion syndrome.

Medical subject headings